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Abstract
Background
The Diabetes Prevention Program (DPP) study showed that weight loss in high-risk adults
lowered diabetes incidence and cardiovascular disease risk. No prior analyses have aggre-
gated weight and cardiometabolic risk factor changes observed in studies implementing
DPP interventions in nonresearch settings in the United States.
Methods and Findings
In this systematic review and meta-analysis, we pooled data from studies in the United
States implementing DPP lifestyle modification programs (focused on modest [5%–7%]
weight loss through150 min of moderate physical activity per week and restriction of fat
intake) in clinical, community, and online settings. We reported aggregated pre- and post-
intervention weight and cardiometabolic risk factor changes (fasting blood glucose [FBG],
glycosylated hemoglobin [HbA1c], systolic or diastolic blood pressure [SBP/DBP], total [TC]
or HDL-cholesterol). We searched the MEDLINE, EMBASE, Cochrane Library, and Clinical-
trials.gov databases from January 1, 2003, to May 1, 2016. Two reviewers independently
evaluated article eligibility and extracted data on study designs, populations enrolled, inter-
vention program characteristics (duration, number of core and maintenance sessions), and
outcomes. We used a random effects model to calculate summary estimates for each out-
come and associated 95% confidence intervals (CI). To examine sources of heterogeneity,
results were stratified according to the presence of maintenance sessions, risk level of par-
ticipants (prediabetes or other), and intervention delivery personnel (lay or professional).
Forty-four studies that enrolled 8,995 participants met eligibility criteria. Participants had
an average age of 50.8 years and body mass index (BMI) of 34.8 kg/m2, and 25.2% were
male. On average, study follow-up was 9.3 mo (median 12.0) with a range of 1.5 to 36
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months; programs offered a mean of 12.6 sessions, with mean participant attendance of
11.0 core sessions. Sixty percent of programs offered some form of post-core maintenance
(either email or in person). Mean absolute changes observed were: weight -3.77 kg (95%
CI: -4.55; -2.99), HbA1c -0.21% (-0.29; -0.13), FBG -2.40 mg/dL (-3.59; -1.21), SBP -4.29
mmHg (-5.73, -2.84), DBP -2.56 mmHg (-3.40, 1.71), HDL +0.85 mg/dL (-0.10, 1.60), and
TC -5.34 mg/dL (-9.72, -0.97). Programs with a maintenance component achieved greater
reductions in weight (additional -1.66kg) and FBG (additional -3.14 mg/dl).
Findings are subject to incomplete reporting and heterogeneity of studies included, and
confounding because most included studies used pre-post study designs.
Conclusions
DPP lifestyle modification programs achieved clinically meaningful weight and cardiometa-
bolic health improvements. Together, these data suggest that additional value is gained
from these programs, reinforcing that they are likely very cost-effective.
Author Summary
Background
• In the United States and in many other countries, rates of both obesity and diabetes con-
tinue to increase every year.
• The US Diabetes Prevention Program (DPP) trial studied people with a high risk of dia-
betes and placed them in a program encouraging adoption of both a healthy diet and
exercise, consisting of 16 core sessions with ongoing support afterwards.
• The DPP trial showed that such a program could decrease the incidence of diabetes and
that it helped people lose weight and decrease their cardiovascular risk factors.
WhyWas This Study Done?
• This study was done to collect all of the available data from programs based on imple-
mentation of the DPP in different settings and to combine them into a large analysis to
understand whether such programs were associated with weight, blood sugar, blood
pressure, and cholesterol.
• Our study was designed specifically to find out if the programs worked, which health
parameters changed and which program characteristics were the most useful.
What Did the Researchers Do and Find?
• We performed a systematic review and meta-analysis by looking at four different data-
bases of articles and selecting all of those which used principles from the DPP.
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• We identified 44 studies with a total of 8,995 participants who were enrolled in different
versions of the DPP.
• These programs differed in many ways from the original DPP trial—they were delivered
in different settings, had different providers, and involved group sessions rather than
individual sessions.
• We found that even with these modifications, the programs were still associated with
favorable changes in weight, blood pressure, cholesterol and blood sugar.
What Do These Findings Mean?
• Programs based on the DPP have the potential to help a large number of people in the
community to lose weight, decrease their risk of diabetes, and help improve other mark-
ers of health.
• These programs could also be a cost-effective way to help prevent diabetes and help peo-
ple live healthier lives.
Introduction
Diabetes currently affects approximately 9.3% of the United States population [1], and by 2050,
its prevalence is expected to reach 25% [2]. Adults with diabetes have two to four times higher
rates of death from heart disease or stroke, and they have medical expenses that are more than
two times higher than those for people without diabetes [3–6]. The total annual economic bur-
den associated with diabetes was US$245 billion in 2012, with US$176 billion incurred as direct
medical expenditures [3]. In addition, 86 million US adults (35% of the population) have predi-
abetes [1], which puts them at over four times the risk of progressing to diabetes compared to
those who are normoglycemic [7,8].
Large randomized controlled studies [9–11], including the US Diabetes Prevention Program
(DPP) trial, have shown that intensive and structured lifestyle modification interventions in
people with impaired glucose tolerance can lower the incidence of diabetes by 30%–58% com-
pared to basic lifestyle advice [10–15]. Although primary prevention of diabetes through life-
style changes is deemed cost-effective, the first-year cost of delivering the original DPP lifestyle
intervention was prohibitive (US$1,399 per participant) [16–18]. In addition, lifestyle and cul-
tural patterns vary significantly, across and even within communities, necessitating tailoring of
interventions according to regional and ethnic differences to achieve effectiveness, acceptabil-
ity, and sustainability [19]. To find acceptable, lower-cost alternatives to the resource-intensive
DPP lifestyle interventions, a number of studies tested adaptations of DPP delivery in typical
US clinics and communities, but still retained the DPP’s core principles of modest weight loss,
calorie-restricted diets, and 150 min of moderate-intensity exercise per week; on average, these
DPP lifestyle interventions were associated with meaningful pre-post weight loss of approxi-
mately 4% [20]. However, it remains unknown whether these nonresearch lifestyle intervention
programs were associated with meaningful changes in glycemic markers (fasting blood glucose
[FBG] and glycosylated hemoglobin [HbA1c]), blood pressure (BP), and lipids (high density
lipoprotein [HDL] and total cholesterol [TC]). Furthermore, there are no comparisons of how
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data from these translation or effectiveness studies compare to metabolic changes observed in
the DPP efficacy trial itself [20,21]. It also remains unclear whether benefits of lifestyle modifi-
cation programs for diabetes prevention are equally beneficial across persons with objectively
defined prediabetes versus those identified only through risk factors for diabetes (e.g., being
overweight and hypertensive), and whether program characteristics (e.g., presence of a mainte-
nance component or type of provider) are associated with better outcomes.
Methods
Study Selection
We systematically searched four electronic databases (MEDLINE, EMBASE, Cochrane Library,
and Clinicaltrials.gov) for translation or effectiveness studies that tested delivery adaptations of
DPP-lifestyle principles in the US and were published between January 1, 2003, and May 1, 2016.
Including studies with a similar exposure (DPP-lifestyle principles), albeit via different delivery
modalities, and similar outcome measurements allows for the heterogeneity in these studies to
answer questions regarding external validity that the original study could not. Indeed, the focus
of this work was to inform wider implementation and scaling of interventions in the US.
The search terms used are listed in S1 Table. We supplemented our searches by hand
searching reference lists of included articles and other reviews of this topic [22].
We included studies if they met three eligibility criteria. First, each study needed to evaluate
implementation of lifestyle intervention programs based on tested DPP principles in US set-
tings. Second, the studies had to have reported pre- and post-intervention estimates for at least
one of the following measures: weight, HbA1c, FBG (venous or capillary), systolic or diastolic
BP (SBP, DBP), HDL, or TC. Finally, each eligible study had to include adults (age18) at
high risk of developing diabetes. To qualify as “high risk,” the target population could have
either of the following criteria:
1. A diagnosis of prediabetes [23,24]. This could be a self-report of a previous medical diag-
nosis, or by blood glucose testing, such as
a. FBG100 mg/dl (impaired fasting glucose [IFG]) or
b. 2 h post-challenge glucose of 140–199 mg/dl (impaired glucose tolerance [IGT]) or
c. Random (nonfasting) blood glucose between 110–199 mg/dl) [25]; or
d. HbA1c of 5.7%–6.4% [24]
OR
2. Presence of risk factors for diabetes:
a. Body mass index (BMI)25 kg/m2 AND one additional risk factor such as previ-
ous gestational diabetes (GDM), family history, or minority race/ethnicity such as
being Asian American, Hispanic, or non-Hispanic US blacks [25]
OR
b. An American Diabetes Association diabetes risk score of greater than 5 [26]
This systematic review and meta-analysis was focused on studies in the US that implemented
specific principles tested in the DPP. The study needed to specifically state that it was DPP
inspired, and have both an exercise and dietary component in its intervention.We excluded stud-
ies with children, adolescents, or lifestyle interventions that did not involve combined diet and
exercise principles tested in the DPP trial. If participants had polycystic ovarian syndrome,
Cardiometabolic Risk Factor Changes in Diabetes Prevention Programs in the US: A Meta-analysis
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current or recent pregnancy, or tested the use of medications (such as metformin) to prevent dia-
betes, these studies were excluded. If studies had a majority of prediabetes participants (greater
than 50%), we included these studies in order to be able to include all available data.
Abstracts were reviewed independently by two authors (UM and AZ) who used the criteria
above to determine study eligibility. All discrepancies were resolved by consensus with a third
study author (MKA.) When necessary information was not reported in the study, authors of
the original article were contacted for further details.
Data regarding study population characteristics, study designs, characteristics of interventions
tested (number of core and maintenance sessions, duration of interventions, and follow up time
periods), and on baseline and follow-up values for each outcome (weight, FBG, HbA1c, SBP,
DBP, HDL, and TC) were extracted by one author (UM) from each eligible article.
Quality Assessment
The DPP trial findings established that standard health advice alone had a low level of efficacy
in reducing diabetes incidence among overweight participants with biochemically confirmed
impaired glucose tolerance and elevated fasting glucose [13]. Structured behavioral modifica-
tion interventions, adherence to rigorous lifestyle principles, and associated weight loss were
shown to be effective [27]. Unlike large trials such as the DPP, translation studies tend to be
small and often use quasi-experimental designs (e.g., single group pre- and post- intervention
or pre-post evaluations with control groups) in which random allocation and blinding are
impossible [13]. To assess study quality and facilitate interpretation of the available literature,
we applied a scoring system with three criteria, each contributing one point in the criteria
adapted from those proposed by Juni et al. [28]. The first criterion assessed whether studies
used any steps to minimize attrition bias by using an intention to treat analysis, achieving low
attrition rates (20%), or by comparing characteristics of completers and noncompleters. The
second criterion was to assign higher quality to studies that included a control group (random-
ized, matched, or unmatched comparison). The third criterion focused on whether the study
reported on four or more of the following aspects of translating evidence: describing the
process of designing the program, describing the enrollment process, documenting session
attendance, reporting costs and/or resource inputs, documenting the training process or quali-
fications of personnel, or describing the qualitative feedback from participants or providers.
The latter was considered an important aspect of study quality given that studies were included
based on their ability to provide information about how DPP lifestyle programs were imple-
mented and how successful they were. These quality assessment criteria were chosen because
they support study replication and comparison. A study was categorized as “high quality” if it
had at least two out of three possible points. Further details are provided in the S3 Table.
Statistical Analysis
Using pooled data, descriptive characteristics of the study populations were calculated as
weighted means based on sample size. Since very few of the studies had comparison groups,
the intervention arms of controlled studies were treated as pre-post groups and aggregated
with the remaining single-group pre-post studies. When studies included multiple intervention
arms, each distinct intervention arm was treated as a separate pre-post group. For example, in
studies in which a lifestyle intervention was delivered using two different media (in person ver-
sus remote), these counted as two separate intervention groups within the same study.
Estimates of pre-post intervention change in each outcome and the corresponding standard
errors were obtained or calculated based on the data reported. To standardize the length of fol-
low-up, we focused on the 1 y interval between pre- and post- intervention measures. If a study
Cardiometabolic Risk Factor Changes in Diabetes Prevention Programs in the US: A Meta-analysis
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conducted several follow-up assessments for a given outcome, the reported value at the time
point closest to 1 y was used to calculate the change from the baseline. We used random effects
meta-analysis techniques to calculate aggregate estimates and measures of dispersion to
account for inter-study heterogeneity. All estimates were accompanied by a χ2 test for hetero-
geneity with a corresponding I2 value.
To explore what program characteristics may have been associated with risk factor changes,
we performed stratified analyses according to delivery format (individual or group), interven-
tion delivery personnel (by health professionals, lay community center staff, or electronic
media), location of the intervention (clinical or community setting), and inclusion of a mainte-
nance component in the study protocol (yes or no). When there was more than one type of
delivery format, the delivery format of the core sessions took precedence. For example, if an
article had core sessions in the community and a remote component for maintenance, this was
coded as “community.” Stratified analyses were conducted for each outcome, except HbA1c,
for which data were insufficient to allow stratification. We also stratified by the method used
for risk classification (blood glucose criteria or risk factor criteria to classify as “high-risk”). We
tested whether any program characteristics were associated with weight change using Spear-
man’s rank correlation analyses. Program characteristics of interest, in addition to those listed
above, included the mean number and duration of core sessions offered, average participant
age and BMI, proportions of males and non-Hispanic whites (NHWs) in the study sample, and
attrition. Lastly, we evaluated aggregate outcomes in high versus average quality studies.
When studies included a control arm, we included them in separate analyses of the inter-
vention arms against the control arms to determine what incremental changes in weight and
cardiometabolic risks was observed.
All calculations were carried out using MIX 2.0 statistical software [29]. Statistically signifi-
cant differences were noted based on a conservative definition of non-overlapping 95% confi-
dence intervals. All findings were reported in reference to the 1 y findings reported by the
original DPP trial [13].
Results
Study and Participant Characteristics
A total of 44 studies, which included 48 intervention groups, met eligibility for inclusion. Of these,
22 studies were single group pre-post designs [30–51], 3 studies had two intervention arms (each
contributing two separate groups for analysis) [52–54], 18 studies had separate control arms [55–
72], and 1 study had three arms—two intervention groups and one control [73]. Data on weight
change from baseline were available from all intervention groups. There were 21 groups that had
pre- and post-intervention data on FBG, 8 had HbA1c measures, 23 had SBPmeasures, 22 had
DBPmeasures, 14 had HDLmeasures, and 12 had TCmeasures. Further details are listed in Fig 1.
A total of 8,995 participants were enrolled across all intervention arms. Aggregate partici-
pant demographic and clinical characteristics were similar to participants enrolled in the origi-
nal DPP study (Table 1). At enrollment, participants’mean age was 50.8 y, mean weight was
99.3 kg, mean BMI was 34.8 kg/m2, 25.2% were male, and 32.9% were non-Hispanic white.
Mean baseline levels of cardiovascular risk factors were: 5.9% (HbA1c), 104.6 mg/dl (FBG),
128.7/79.5 mmHg (SBP/DBP), 46.1 mg/dl (HDL), and 183.7 mg/dl (TC). Of the 48 interven-
tion groups, 18 used blood glucose measures to classify risk for diabetes, 22 used the presence
of risk factors, and 8 included participants defined as high risk by either of the above criteria.
Programs amended the original DPP lifestyle intervention (Table 1) by changing the num-
ber or duration of core sessions offered (the DPP offered 16 in-person sessions over 24 wk),
conducting group (instead of individual) sessions, modifying the type of lifestyle coach (DPP
Cardiometabolic Risk Factor Changes in Diabetes Prevention Programs in the US: A Meta-analysis
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coaches were qualified dietitians, exercise physiologists, behavioral psychologists, or health
educators), and changing or removing the monthly maintenance component where partici-
pants met or were contacted for the remainder of the follow-up period to promote continued
adherence to healthy lifestyle principles.
Fig 1. Flow diagram of study search. This flow chart describes the number of studies that were involved in each step of the process of
study selection, from the initial study search. After the application of inclusion and exclusion criteria, 44 studies met criteria and were
included in the final analysis.
doi:10.1371/journal.pmed.1002095.g001
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The number of core sessions offered in included DPP-lifestyle programs ranged from 1 to
24, with a mean of 12.6 core sessions (median 12.0) offered and 11.0 mean core sessions
attended (median 10.1). Thirty interventions incorporated a maintenance component, which
varied from emails to intermittent in-person group sessions. Programs with scheduled mainte-
nance ranged from 3–8 monthly sessions as follow-up after the initial core component. Mean
study duration was 9.3 mo with a standard deviation (SD) of 5.5 mo and a range from 3 to 15
mo (median 12.0) Across all studies, overall attrition was 23.5% (range: 0.0 to 43.2).
Outcomes
Across all studies, mean absolute pre-post weight change was -3.77 kg (95% CI: -4.55 to 2.99,
I2 of 99.06% (95% CI: 98.96, 99.15) (Table 2). Aggregate data from 16 studies that randomly
assigned participants to intervention or control groups showed 2.66 kg greater weight loss
among intervention participants (-3.25 kg) compared to control participants (-0.59 kg). For
further details, see forest plot in S13 Fig.
Table 1. Baseline characteristics of trials (aggregate) versus DPP.
DPP trial (lifestyle arm) Included trials (IQR)
Age (years) 50.6 50.8 (49.0–56.4)
BMI 33.7 34.8 (32.2–36.6)
Male (%) 32.0 25.2% (15.0–31.3)
NHW (%) 53.8 32.9% (0.0–86.0)
Weight (kg) 93.5 99.3(91.5–101.7)
HbA1c (%) 5.9 5.9 (5.7–6.0)
FBG (mg/dl) 106.3 104.6 (99.0–107.6)
SBP (mm Hg) 124 128.7 (123.5–133.6)
DBP (mm Hg) 78 79.5 (77.2–82.5)
HDL (mg/dL) 46.0 46.1 (44.7–49.7)
Total Cholesterol
(mg/dL)
NR 183.7 (183.0–192.1)
Screening method Impaired fasting and elevated post-load
glucose
Impaired fasting or elevated post load
glucose or other high risk
Core lifestyle
sessions offered
16 Mean 12.6 (Range 1–24, median 12.0)
Core lifestyle
sessions attended
NR Mean 11.0 (Range 3.67–25, median 10.1)
Type of sessions 100% Individual 16.7% individual, 70.8% group, 12.5%
both
Setting Clinical centers across US Clinics, Community centers, Churches,
Worksite, Internet
Duration of follow-
up
Mean 2.8 y (Range 1–4 y) Mean 9.3 mo, (Range 3–36, Median 12.0)
Maintenance Yes (100%) Sometimes (62.5%)
Delivery personnel Mostly dieticians; also coaches with at
least a master’s degree training in
exercise physiology, behavioral
psychology, or health education
Clinical personnel (physicians, nurses,
dieticians, grad students) and nonclinical
delivery (Internet-based classes and other
lay community volunteers who underwent
training)
NR = not reported; BMI = body mass index; HbA1c = hemoglobin A1c; NHW = non-Hispanic white;
SBP = systolic blood pressure; DBP = diastolic blood pressure; FBG = fasting blood glucose; HDL = high
density lipoprotein cholesterol
doi:10.1371/journal.pmed.1002095.t001
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Among 8 studies that measured HbA1c, mean pre-post change was -0.21% (95% CI: -0.29;
-0.13, I2 82.72% [95% CI: 67.29%, 90.87.]) Among 21 studies reporting FBG, mean change in
FBG was -2.40 mg/dl (95% CI: -3.59; -1.21, I2 90.63% [95% CI: 87.08, 93.21]). Among the 23
studies evaluating BP, we observed a mean pre-post change in SBP of -4.29 mmHg (95% CI:-
5.73, -2.84, I2 75.40% [95% CI: 61.15, 84.43]) and -2.56 mmHg in DBP (95% CI:-3.40, 1.71, I2
57.96% [95% CI: 29.09, 75.08]). There were 14 and 12 studies which reported on HDL and
total cholesterol, respectively. There was an overall pre-post increase in HDL of +0.85 mg/dL
(95% CI: -0.10, 1.60, I2 63.12% [95% CI: 34.41, 79.26]) and change in TC of -5.34 mg/dl (95%
CI: -9.72, -0.97, I2 56.09% [95% CI: 16.19, 76.99]). There were insufficient data to perform
between-group comparisons (intervention versus control) for outcomes other than weight.
Stratified Analyses
Using our conservative definition of non overlapping CIs, studies with a maintenance compo-
nent had a statistically significantly greater decrease in mean FBG (-3.14 mg/dl) and a greater
decrease in weight (-1.66 kg) than intervention programs without a maintenance component
(Table 3).
No statistically or clinically significant differences in risk factor changes were observed
when comparing studies testing interventions delivered by community workers to studies that
employed health professionals, or those that used electronic media (Table 4). Similarly, no out-
come differences were noted in studies classifying high-risk for diabetes based on blood glucose
testing versus other criteria (Table 5), nor by study quality, (high versus average quality) or set-
ting (clinic, community or remote). (Data shown in S7, S11 and S10 Figs).
Discussion
This is the first meta-analysis to aggregate both weight and cardiovascular risk factor changes
from US community-based studies of DPP-based lifestyle interventions. Characteristics of par-
ticipants in these studies of DPP lifestyle programs were very similar to those of the original
trial participants, but translation study participants had a slightly higher mean starting weight
and higher proportion of females [13]. The original DPP participants had a greater mean
weight loss at 1 y than the participants in this meta-analysis (6.8 kg versus 3.8 kg), which was
likely due to the more resource intensive intervention and individualized support in the trial
[13]. However, this weight change was closer to the 4.2 kg weight loss reported in the Finnish
Diabetes Prevention Study (DPS) [11]. Studies with adequate control groups showed an addi-
tional 1.9 kg weight lost across intervention arms when compared with their respective control
arms (3.3 versus 0.6 kg). Indeed, the control groups in these effectiveness studies achieved
Table 2. Comparison of outcomes from DPP versus Community Trials.
Value Number of
intervention groups
Mean* baseline Mean change* at study
completion (95% CI)
DPP trial at last DPP
annual (avg 2.9 y)
Weight (kg) 48 99.3 -3.77 (-4.55, -2.99) - 5.6
A1c (%) 8 5.9 -0.21 (-0.29, -0.13) - 0.10
FBG (mg/dl) 21 104.6 -2.40 (-3.59, -1.21) -5.0
SBP (mm Hg) 23 128.7 -4.29 (-5.73, -2.84) -4.0
DBP (mm Hg) 22 79.5 -2.56 (-3.40, 1.71) -4.0
HDL (mg/dL) 14 46.1 +0.85 (-0.10, 1.60) +1.16
Total Cholesterol (mg/dL) 12 183.7 -5.34 (-9.72, -0.97) NR
*Mean indicates average of study means
doi:10.1371/journal.pmed.1002095.t002
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some benefit from participation, even if only exposed to minimal intervention. Compared to
the original DPP, HbA1c, and SBP reductions observed in translation studies were similar;
FBG and DBP reductions were somewhat lower than the reductions achieved in the efficacy
trial; and comparisons for HDL and TC were not possible.
Fig 2. Mean weight change of study participants. Analysis of all 48 intervention groups which reported weight change from baseline to end of
follow-up period. Data was analyzed with Mix 2.0 using random effects method with the weighting of each study proportional to the inverse of the
variance. Study weight is indicated by the size of the box, and horizontal lines indicate the 95% confidence interval. The red line indicates the
overall weight change, and summary diamond indicates pooled estimate with reported mean (95%CI).
doi:10.1371/journal.pmed.1002095.g002
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We noted no difference in cardiometabolic risk factor changes in people with biochemically
confirmed prediabetes versus those with diabetes risk factors. That said, progression to diabetes
and its complications varies by type of prediabetes. The DPP enrolled patients with both IGT
and IFG, who are at approximately three times higher risk of progression to diabetes compared
to those with IFG alone [7]. The Finnish DPS, Malmo, and Da Qing studies also included par-
ticipants with IGT or combined IGT and IFG, who are at higher risk than those with IFG alone
[7,9,14]. Meanwhile, the US-based DPP-translation studies primarily used IFG criteria, and
none used oral glucose tolerance tests to determine high-risk status. This suggests that partici-
pants in these studies had a lower risk profile, which was also reflected in their lower baseline
FBG and HbA1c levels. Assuming the participants in this analysis were at a lower baseline risk,
the changes in cardiometabolic risks observed were commensurate with the starting risk level,
and are therefore still noteworthy. It remains unclear whether the DPP intervention is effective
in preventing diabetes among participants with impaired fasting glucoses but normal post-load
glucose levels. Also, given ease of testing, HbA1c is now commonly used to diagnose prediabe-
tes, and it is unclear whether DPP results can be extended to this prediabetes population
defined by HbA1c.
Our findings are also similar to other recent studies. A Community Guide Review, which
evaluated interventions across diverse countries and settings, had similar decreases in FPG
with a nonsignificant trend towards decreased blood pressure and cholesterol [22]. The
MOVE! program evaluated a ten-module program among 238,000 veterans; high intensity
intervention participants achieved 2.7% weight loss at 6 mo compared to a 0.6% weight loss in
the low intensity group [13,74]. Our findings were also similar to a systematic review and
meta-analysis that pooled 22 studies published before July 2012 that translated diabetes pre-
vention for real-life settings in multiple countries (US, Australia, Europe, and Japan) and had
12 mo of follow-up [75]. Since multiple countries were involved, heterogeneous study inter-
ventions were benchmarked to Europe-wide diabetes prevention implementation guidelines
and showed overall pre-post changes in weight (-2.32 kg), HbA1c (-0.13 mmol/mol), FPG
(-0.10 mmol/L [-1.8 mg/dl]), SBP and DBP (-4.30/-4.28 mmHg), HDL (+0.01 mmol/L [+0.39
Table 3. Outcomes stratified by the presence of maintenance. (Supporting forest plot in S9 Fig.)
Outcome Maintenance 95% CI No maintenance 95% CI
Weight (kg) -4.36 (-5.47,-3.26) -2.70 (-3.59, -1.80)
FBG* (mg/dl) -4.00 (-4.93, -3.07) -0.86 (-2.75, 1.03)
SBP (mmHg) -4.62 (-6.48, -2.76) -3.81 (-6.34, -1.27)
DBP (mmHg) -2.27 (-3.26, -1.29) -3.34 (-5.08, -1.60)
HDL (mg/dl) +1.31 (0.38, 2.23) -0.22 (-1.45, 1.02)
TC (mg/dl) -4.09 (-10.50, 2.32) -6.33 (-15.00, -0.51)
* indicates statistically signiﬁcant difference based on non-overlapping conﬁdence intervals
doi:10.1371/journal.pmed.1002095.t003
Table 4. Outcomes stratified by type of provider for delivery of the intervention. (Supporting forest plot in S8 Fig.)
Outcome Electronic (95% CI) Community (95% CI) Clinical (95% CI)
Weight (kg) -5.02 (-5.72, -4.32) -3.13 (-4.66, -1.59) -3.77 (-4.66, -2.88)
FBG (mg/dl) -3.08 (-5.22, -0.94) +1.78 (-4.47, 8.04) -2.87 (-4.34, -1.40)
SBP (mmHg) -4.26 (-7.21, -1.30) -4.06 (-6.84, -1.28) -4.53 (-6.80, -2.27)
DBP (mmHg) -1.34 (-3.24, 0.56) -2.64 (-4.29, -1.00) -2.97 (-4.14, -1.80)
HDL (mg/dl) +0.64 (-1.22, 2.51) +1.92 (-0.92, 4.75) +0.87 (-0.05, 1.79)
TC (mg/dl) -5.76 (-15.3, 3.77) -0.63 (-24.47, 25.74) -5.80 (-10.48, -1.12)
doi:10.1371/journal.pmed.1002095.t004
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mg/dl]), and TC (-0.18 mmol/L [-6.96 mg/dl]); importantly, greater adherence to recommen-
dations was associated with larger weight reduction. Our study expands on this work with a
larger number of pooled studies and participants, all using a similar core set of intervention
principles and comparison to the original DPP Study.
Effective translation of a program depends on multiple components, including referral,
uptake, engagement, completion, and post-program sustainability of outcomes in the whole
population. In our review, after eligibility criteria was applied, 25.5% of all eligible participants
did not enroll; of those who enrolled, there was an additional 23.8% attrition. Rates of attrition
also inherently select for those who are the most motivated participants, which biases the
results towards effectiveness. This limits the generalizability of our findings, which more accu-
rately apply to those who complete the program.
Implementation of DPP lifestyle programs have been limited by both cost and sustainability
of ongoing program participation and risk factor reductions [76]. Most of the programs studied
in this analysis provided free testing and intervention supplies but offered few additional incen-
tives to encourage participation. The most common methods used to decrease cost were modi-
fications to the intervention, such as offering the intervention in accessible locations, delivering
the intervention through lay providers, and taking advantage of group classes and electronic
delivery options. Over 80% of studies tested group interventions, most had fewer mean core
sessions compared to DPP, and only 60% offered a maintenance component. Importantly, we
noted similar risk factor benefits were achievable in interventions delivered by different provid-
ers in both group and individual formats. The similarities in weight loss and secondary out-
comes compared to the DPP is encouraging for the ability to make the intervention cost-
effective without sacrificing the effectiveness. With options that include group sessions, com-
munity-based programs with social support, cultural tailoring, and remote low-cost mainte-
nance such as text messages or phone calls, the interventions allow for scaling to a wider
audience.
Reach and sustainability of behavior change interventions remain, as do other challenges of
implementing diabetes prevention. The advantages of community-based interventions that
were pooled in this study include familiar context, peer support, and convenience to facilitate
continued participation. The success of electronic and remote interventions is also encourag-
ing, as these could be distributed nationally with ease. The option of pre-recorded workouts on
in-home cable TV illustrates a low-cost method of delivery that does not necessitate travel and
is available on demand, in contrast to on-site workout regimens for which participants pay to
participate [77]. This preliminary analysis also suggests that programs that implemented a
maintenance component after the completion of the core sessions had greater reductions in
weight and fasting glucose. The duration and intensity of maintenance that is most effective
and the utility after the 1 y mark is largely unknown. Further evaluation of types of mainte-
nance programs following a year-long program would be helpful to understand long-term ben-
efit and sustainability.
Table 5. Outcomes stratified by method used to determine “high risk” status. (Supporting forest plots in S7 Fig.)
Outcome Blood glucose criteria (95% CI) Risk factor criteria (95% CI) Either (95% CI)
Weight (kg) -3.23 (-4.52, -1.95) -3.62 (-4.67, -2.57) -5.04 (-6.34, -3.74)
FBG (mg/dl) -2.40 (-4.12, -0.67) -0.66 (-5.17, 3.84) -3.27 (-4.62, -1.92)
SBP (mmHg) -2.46 (-4.07; -0.84) -4.92 (-8.12, -1.72) -5.04 (-7.46, -2.62)
DBP (mmHg) -4.66 (-7.54; -1.77) -1.91 (-3.40, -0.42) -2.74 (-3.52, -1.96)
HDL (mg/dl) +0.46 (-0.47, 1.39) +0.99 (-0.95, 2.92) +1.13 (-0.31, 2.57)
TC (mg/dl) -11.94 (-17.80, -6.08) +0.57 (-10.83, 22.23) -5.47 -(10.48,-0.46)
doi:10.1371/journal.pmed.1002095.t005
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Limitations
A key limitation of our analysis was the heterogeneity of the studies included, which is inherent
in all meta-analyses. Differences in duration of follow-up (from 1.5 to 36 mo), location of deliv-
ery, and other delivery format adaptations of the original DPP program were the most likely
sources of heterogeneity. However, as the intervention (DPP-lifestyle program principles) and
outcomes were similar, this study adds to the literature by providing external validity and note-
worthy pre-post and between group cardiometabolic risk factor changes.
The lack of statistical significance found in most of the stratified analyses is likely due to
lack of statistical power, which resulted in large, overlapping confidence intervals, as well as
our conservative definition of statistical significance based only on non-overlapping CI’s. As
most meta-analyses, our study is confined to the use of previously reported results. We used a
more conservative definition of statistical significance by comparing stratum specific results,
though this did not allow a more consistent adjustment for confounders. However, a less con-
servative analytical approach may have found other program characteristics that had “statisti-
cally significant” associations with cardiometabolic changes.
Additionally, studies varied significantly in quality. We conducted a sensitivity analysis to
evaluate change in weight stratified by study quality (high versus average quality), which
showed no significant difference. However, this alone is not expected to account for variation
that arises during recruitment, enrollment, and study conduct. The majority of studies in our
review used pre-post single group study designs and may be subject to confounding. To address
this, we separately examined studies that had control groups and demonstrated that interven-
tion groups achieved larger benefits than control groups.
Conclusion
Delivery of lifestyle programs adhering to DPP principles tested in community and clinical set-
tings achieved similar 1 y decreases in weight, FBG, and HbA1c as the original DPP study,
despite the modifications made to lower cost and improve acceptability across various settings.
Though unclear if these changes truly translate into reductions in diabetes incidence, prior
studies have found decreased incidence to be most closely related to weight loss [13]. Methods
to increase uptake and decrease attrition are both needed to enable long-lasting, sustainable
lifestyle change in patients with the highest risk of progression to diabetes and its associated
complications.
Disclaimer
The findings and conclusions in this report are those of the authors and do not necessarily rep-
resent the official position of the US Centers for Disease Control and Prevention.
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